Life Sciences VCs Confront Difficult Reality in LP Appetites

If you don't eat your life sciences portfolio, you can't have any Sequoia for dessert! As LPs continue to digest medical technology VC investments, GPs are left hungry for more capital.

9 May 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail